Gilger, Brian C.
Brian C. Gilger Americký veterinární lékař, profesor oftalmologie, specialista na oční nemoci koní. Publikace a odborné články z oboru.
Gilger, Brian C., 19..-....
Gilger, Brian C., 1962-
Gilger, Brian 1962-
VIAF ID: 24894308 (Personal)
Permalink: http://viaf.org/viaf/24894308
Preferred Forms
- 100 0 _ ‡a Brian C. Gilger ‡c Americký veterinární lékař, profesor oftalmologie, specialista na oční nemoci koní. Publikace a odborné články z oboru.
- 200 _ | ‡a Gilger ‡b Brian C.
- 100 1 _ ‡a Gilger, Brian C.
-
-
- 100 1 _ ‡a Gilger, Brian C.
-
- 100 1 _ ‡a Gilger, Brian C., ‡d 19..-....
-
- 100 1 _ ‡a Gilger, Brian ‡d 1962-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
AAV Gene Therapy for MPS1-associated Corneal Blindness | |
AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis. | |
Anomalous nasolacrimal openings in a 2-year-old Morgan filly. | |
Bartonella vinsonii subspecies berkhoffi as a possible cause of anterior uveitis and choroiditis in a dog. | |
Best practice recommendations for prehospital veterinary care of dogs and cats. | |
Bilateral nodular lymphocytic conjunctivitis in a horse | |
Carbon dioxide laser photoablation adjunctive therapy following superficial lamellar keratectomy and bulbar conjunctivectomy for the treatment of corneolimbal squamous cell carcinoma in horses: a review of 24 cases. | |
Causes of endogenous uveitis in cats presented to referral clinics in North Carolina | |
Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses | |
Concerns with analysis of correlated eye data. | |
Cosmetic globe surgery in the horse. | |
Cytokine and chemokine profiles of aqueous humor and serum in horses with uveitis measured using multiplex bead immunoassay analysis. | |
A defect in the NOG gene increases susceptibility to spontaneous superficial chronic corneal epithelial defects (SCCED) in boxer dogs | |
Diagnosis and treatment of lens diseases | |
Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement. | |
Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro | |
Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model. | |
Effect of ophthalmic Nd:YAG laser energy on intraocular lenses after posterior capsulotomy in normal dog eyes. | |
Effect of three treatment protocols on acute ocular hypertension after phacoemulsification and aspiration of cataracts in dogs. | |
The effect of topical administration of atropine sulfate on the normal equine pupil: influence of age, breed and gender. | |
Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal. | |
Equine eosinophilic keratitis in horses: 28 cases (2003-2013). | |
Equine glaucoma. | |
Equine ophthalmology | |
Equine orbital fractures: a review of 18 cases (2006-2013). | |
Equine recurrent uveitis: The viewpoint from the USA | |
Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. | |
Evaluation of diode endoscopic cyclophotocoagulation in bovine cadaver eyes. | |
Evaluation of Intracameral Pentablock Copolymer Thermosensitive Gel for Sustained Drug Delivery to the Anterior Chamber of the Eye. | |
Extraocular lymphoma in the horse. | |
Factors associated with postoperative complications in healthy horses after general anesthesia for ophthalmic versus non-ophthalmic procedures: 556 cases (2012-2014) | |
Histiocytic chorioretinitis in a dog. | |
Immune Relevant Models for Ocular Inflammatory Diseases. | |
Immunology of the ocular surface. | |
Impact of fungal species cultured on outcome in horses with fungal keratitis. | |
In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs | |
Keratometry, biometry and prediction of intraocular lens power in the equine eye. | |
Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice. | |
Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs. | |
Modified lamellar keratoplasties for the treatment of deep stromal abscesses in horses | |
A moment of SCIENCE . . . Please! | |
Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States | |
Multifocal electroretinogram in rhodopsin P347L transgenic pigs | |
Nasal adenocarcinoma with diffuse metastases involving the orbit, cerebrum, and multiple cranial nerves in a horse. | |
Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery. | |
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. | |
Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes. | |
Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness. | |
Ocular pharmacology and toxicology | |
Optic neuritis in dogs: 96 cases (1983-2016). | |
Optimizing corneal riboflavin administration in ex vivo horse, dog, rabbit, and pig samples for use in corneal collagen cross-linking | |
Phacoemulsification and aspiration for cataract management in a dollar sunfish, Lepomis marginatus (Holbrook)--a case report. | |
Pharmacologically defined components of the normal porcine multifocal ERG. | |
Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease | |
Presumed primary ocular lymphangiosarcoma with metastasis in a miniature horse. | |
Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. | |
Proteinases of the cornea and preocular tear film. | |
Quantitative differences in mRNA expression of toll-like receptor (TLR)-2, -4, and -9 in normal equine eyes and eyes with equine recurrent uveitis | |
Re: Recovery of canine retina and optic nerve function after acute elevation of intraocular pressure | |
Retrobulbar pigmented peripheral nerve sheath tumor in a dog. | |
Retrospective evaluation of phacoemulsification and aspiration in 41 horses (46 eyes): visual outcomes vs. age, intraocular lens, and uveitis status. | |
Serotype survey of AAV gene delivery via subconjunctival injection in mice | |
Spectral-domain optical coherence tomography evaluation of the cornea, retina, and optic nerve in normal horses | |
Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: A case series | |
Superficial, nonhealing corneal ulcers in horses: 23 cases (1989-2003). | |
Surgical removal of cataracts due to Diplostomum species in Gulf sturgeon (Acipenser oxyrinchus desotoi) | |
Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity. | |
Sustained release cyclosporine therapy for bilateral keratoconjunctivitis sicca in a red wolf (Canis rufus). | |
Sustained Release of Protein Therapeutics from Subcutaneous Thermosensitive Biocompatible and Biodegradable Pentablock Copolymers (PTSgels) | |
Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery | |
Topical delivery of aqueous micellar resolvin E1 analog (RX-10045) | |
Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices. | |
Use of a hydroxyapatite orbital implant in a cosmetic corneoscleral prosthesis after enucleation in a horse. | |
Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study. |